* Cano Health Inc CANO.N CANO.K is expected to show a
rise in
quarterly revenue when it reports results on March 1.
* The Miami Florida-based company is expected to report a
32.4% increase in revenue to $651.64 million from $492.26
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cano Health Inc is
for a
loss of 13 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cano Health
Inc
is $4, above its last closing price of $1.60.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.03 -0.05 -0.23 Missed -384.9
Jun. 30 2022 -0.04 -0.05 -0.03 Beat 44.1
Mar. 31 2022 -0.08 -0.07 0.00 Beat 98.5
Dec. 31 2021 -0.06 -0.02 0.00 Beat 100
Sep. -0.01 -0.01 -0.09 Missed -1,223
30 2021 .5
Jun. 30 2021 -0.01 -0.01 0.01 Beat 200
This summary was machine generated February 27 at 22:05 GMT.
All figures in US dollars unless otherwise stated